SG Americas Securities
LXEO icon

SG Americas Securities’s Lexeo Therapeutics LXEO Stock Holding History

SG Americas Securities’s Portfolio LXEO Stock Details LXEO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$49K Buy
+10,555
New +$57.1K ﹤0.01% 3208
2026
Q1 		– Sell
-18,640
Closed -$185K – 3491
2025
Q4 		$185K Buy
+18,640
New +$170K ﹤0.01% 2962
2025
Q1 		– Sell
-10,960
Closed -$72K – 3624
2024
Q4 		$72K Buy
+10,960
New +$86.3K ﹤0.01% 2832

Other funds holding LXEO

SCM
Suvretta Capital Management New York $5.47B AUM 131.34% 1-Year Est. Return
AAA
Affinity Asset Advisors New York $2.21B AUM 431.26% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return
FLSM
Frazier Life Sciences Management Palo Alto, California $4.59B AUM 237.58% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
VPC
Vestal Point Capital New York $4.28B AUM 239% 1-Year Est. Return
PBA
Paradigm Biocapital Advisors New York $5.34B AUM 380.18% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
O
OrbiMed New York $5.4B AUM 163.13% 1-Year Est. Return

SG Americas Securities's LXEO Position: Q2 2026 in Review

SG Americas Securities opened a new position in Lexeo Therapeutics (LXEO) in Q2 2026: 10,555 shares worth $49K. The stake represents ﹤0.01% of the portfolio and ranks #3208 among its holdings. This is a return to the name: SG Americas Securities previously reported a position in LXEO as recently as Q4 2025.

SG Americas Securities first reported a position in LXEO in Q4 2024 and has held it in 3 quarters since. The position peaked at $185K in Q4 2025. 141 funds tracked by Wall St. Rank hold LXEO as of Q2 2026.

  • SG Americas Securities held 10,555 shares of Lexeo Therapeutics worth $49K as of Q2 2026.
  • Lexeo Therapeutics was a new SG Americas Securities position in Q2 2026.
  • Lexeo Therapeutics made up ﹤0.01% of SG Americas Securities's portfolio in Q2 2026, its #3208 holding.
  • SG Americas Securities first reported a position in Lexeo Therapeutics in Q4 2024 and has held it in 3 quarters since.
  • SG Americas Securities's Lexeo Therapeutics position peaked at $185K in Q4 2025.
  • 141 funds tracked by Wall St. Rank held Lexeo Therapeutics as of Q2 2026.

Based on SG Americas Securities's 13F filing for Q2 2026, filed 7 Aug 2026.